Cellular activities are dictated by proteins. Deciphering how proteins interact in a healthy or diseased state is a key area of interest in biology. Eventually, this will facilitate the development of drugs for many diseases including cancer, which is ultimately the result of misregulated protein homeostasis.In recent years, affinity purification coupled to mass spectrometry (AP-MS) has been the preferred method to identify cellular protein-protein interactions. Unfortunately, AP-MS experiments typically require large amounts (millions of cells) of input material. For this reason, AP-MS studies are mostly restricted to cancer cell lines that can be grown in large quantities in vitro. Cristina Furlan and René Dirks from the groups of Michiel Vermeulen and Hendrik Marks, research theme Cancer development and immune defense, teamed up to address these limitations by developing a low input AP-MS workflow, called on-chip AP-MS, which can be used to perform AP-MS experiments using a few micrograms of lysate from a few thousand cells. This was achieved by implementing an AP-MS method in a automated, microfluidic device from the company Fluidigm using nanoliter volumes.
With the development of on-chip AP-MS, clinical samples, rare cell types and organoids, which are difficult to obtain in large quantities, can now be investigated using interaction proteomics studies. The field of mass spectrometry-based interaction proteomics is thus taking an important next step towards applications in biology and medicine which thus far, due to technical constraints, have remained elusive. This study was recently published in Nature Communications.
Related news items
European Commission Initiative on Breast Cancer (ECIBC) Guidelines13 August 2019
In Annals of internal medicine Mireille Broeders and colleagues from the ECIBC Guidelines Development Group described the methods used to develop person-centered evidence-based recommendations for screening and diagnosis of breast cancer.read more
Circulation publication for exercise physiologists13 August 2019
Thijs Eijsvogels and Vincent Aengevaeren showed that exercise-incuded elevations of troponin concentrations are predictive of major adverse cardiovascular events and mortality.read more
DELA, Radboudumc and Games for Health start a new project to fight loneliness among elderly using games12 August 2019
More than half of people aged 75 and over feel their selves lonely every now and then. A special collaboration between DELA, Radboudumc, and Games for Health will investigate whether joined gaming between elderly and young people can alleviate this social problem.read more
A warm welcome for a new RIMLS colleague Nico Sommerdijk5 August 2019
As of 1 August we welcome Nico Sommerdijk as our new colleague at the RIMLS. Nico will join the department of Biochemistry, with his research group “Biochemistry of Mineralized Tissues”.read more